Physician profile
Susan Lee
NPI 1932273596
$6,292.09
in general payments reported to CMS, 2019-2025
18 companies · $272 in 2025
The $272 reported for 2025 was more than what a typical Psychiatry provider received nationally (typical 2025 total: $176).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,530 · 2020: $844 · 2021: $229 · 2022: $163 · 2023: $98.58 · 2024: $154 · 2025: $272.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $525.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $525.46 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $1,639.27 | 2019-2020 | |
| Otsuka America Pharmaceutical, INC. | $880.89 | 2019-2020 | |
| Alkermes, INC. | $624.80 | 2019-2020 | |
| Takeda Pharmaceuticals U.S.A., INC. | $580.77 | 2019-2021 | |
| Sunovion Pharmaceuticals INC. | $494.38 | 2019-2021 | |
| Teva Pharmaceuticals USA, INC. | $382.43 | 2019-2025 | Uzedy |
| Lundbeck LLC | $335.17 | 2019-2021 | |
| Neurocrine Biosciences, INC. | $298.32 | 2019 | |
| Otsuka Pharmaceutical Development & Commercialization, INC. | $241.60 | 2019-2020 | |
| Abbvie INC. | $211.61 | 2022-2023 | |
| Janssen Pharmaceuticals, INC | $170.15 | 2019-2020 | |
| Madrigal Pharmaceuticals | $150.00 | 2025 | Rezdiffra |
| Grifols USA, LLC | $125.00 | 2024 | Hyperrab |
| Supernus Pharmaceuticals, INC. | $79.17 | 2023-2024 | Qelbree, Qelbree |
| Eisai INC. | $24.86 | 2021 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Gilead Sciences, INC. | $22.59 | 2019 | |
| Bausch Health US, LLC | $16.92 | 2019 | |
| Shire North American Group INC | $14.16 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Susan Lee listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.